Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Friday, January 31, 2025 1 min read

Key Takeaway: Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union

Full Press Release Details

Update on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European Union.